Technical Analysis for XAIR - Beyond Air, Inc.

Grade Last Price % Change Price Change
B 7.86 10.39% 0.74
XAIR closed up 10.39 percent on Tuesday, July 27, 2021, on 1.33 times normal volume.
Earnings due: Aug 4
*** please verify all earnings dates ***

Trend Table & Recent EOD Trading Signals

ADX Long Term Intermediate Term Short Term
Strong Up Up Up
Historical XAIR trend table...

Date Alert Name Type % Chg
Wide Bands Range Expansion 0.00%
Upper Bollinger Band Touch Strength 0.00%
1,2,3 Pullback Bullish Bullish Swing Setup 10.39%
Non-ADX 1,2,3,4 Bullish Bullish Swing Setup 10.39%
Wide Bands Range Expansion 10.39%
Down 3 Days in a Row Weakness 10.39%
Boomer Buy Setup Bullish Swing Setup -1.75%
Calm After Storm Range Contraction -1.75%
NR7 Range Contraction -1.75%
Upper Bollinger Band Walk Strength -1.75%
Older End-of-Day Signals for XAIR ...

   Recent Intraday Alerts -- Get these alerts pushed to you via our Mobile App

Get this analysis on your stocks daily!

Let us help you stay on top of your investments. We will alert you to important technical developments on your portfolio & watchlist.


Beyond Air, Inc. Description

Beyond Air, Inc. is a clinical-stage medical device and biopharmaceutical company developing a revolutionary NO Generator and Delivery System that uses NO generated from ambient air and delivers precise amounts of NO to the lungs for the potential treatment of respiratory and other diseases. The Beyond Air NO Delivery System can generate up to 400 ppm of NO for delivery either continuously or for a fixed amount of time and has the ability to either titrate dose on demand or maintain a constant dose. The Company is currently applying its therapeutic expertise to develop treatments for pulmonary hypertension in various settings, in addition to treatments for lower respiratory tract infections that are not effectively addressed with current standards of care. Beyond Air is currently advancing its revolutionary NO Generator and Delivery System in clinical trials for the treatment of bronchiolitis and severe lung infections such as nontuberculous mycobacteria (NTM).


Sector: Industrials
Industry: Conglomerates
Keywords: Medicine Biopharmaceutical Hypertension Coronavirus Pulmonary Hypertension Bacterial Diseases Tuberculosis Bacteriology Lung Infection Lower Respiratory Tract Infection Lung Infections Mycobacterium Nontuberculous Mycobacteria Respiratory And Other Diseases Respiratory Tract Respiratory Tract Infection

Is XAIR a Buy, Sell or Hold?

Indicator Bull Case Neutral / Hold Bear Case
50 DMA
200 DMA
ADX Trend
Oversold / Overbought
Relative Strength


Indicator Value
52 Week High 9.3
52 Week Low 4.63
Average Volume 567,694
200-Day Moving Average 5.77
50-Day Moving Average 5.94
20-Day Moving Average 6.81
10-Day Moving Average 7.27
Average True Range 0.65
ADX 36.64
+DI 34.70
-DI 15.55
Chandelier Exit (Long, 3 ATRs) 7.35
Chandelier Exit (Short, 3 ATRs) 7.70
Upper Bollinger Bands 8.25
Lower Bollinger Band 5.36
Percent B (%b) 0.86
BandWidth 42.43
MACD Line 0.51
MACD Signal Line 0.42
MACD Histogram 0.0881
Fundamentals Value
Market Cap 136.32 Million
Num Shares 17.3 Million
EPS -1.49
Price-to-Earnings (P/E) Ratio -5.26
Price-to-Sales 113.89
Price-to-Book 5.70
Pivot Point Level Traditional / Classic Fibonacci Demark Woodie Camarilla
Resistance 4 (R4) 9.65
Resistance 3 (R3) 9.59 8.93 9.35
Resistance 2 (R2) 8.93 8.48 8.96 9.25
Resistance 1 (R1) 8.40 8.20 8.67 8.46 9.15
Pivot Point 7.74 7.74 7.88 7.77 7.74
Support 1 (S1) 7.21 7.29 7.48 7.27 6.57
Support 2 (S2) 6.55 7.01 6.58 6.47
Support 3 (S3) 6.02 6.55 6.37
Support 4 (S4) 6.08